Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/768408/000143774919013217/cyan20190331_10k.htm
August 2023
August 2023
August 2023
July 2023
June 2023
May 2023
December 2022
August 2022
June 2022
November 2021
Document And Entity Information - USD ($) | 12 Months Ended | ||
---|---|---|---|
Mar. 31, 2019 | Jun. 17, 2019 | Sep. 30, 2018 | |
Document Information [Line Items] | |||
Entity Registrant Name | Cyanotech Corp | ||
Entity Central Index Key | 0000768408 | ||
Trading Symbol | cyan | ||
Current Fiscal Year End Date | --03-31 | ||
Entity Filer Category | Non-accelerated Filer | ||
Entity Current Reporting Status | Yes | ||
Entity Voluntary Filers | No | ||
Entity Well-known Seasoned Issuer | No | ||
Entity Emerging Growth Company | false | ||
Entity Small Business | true | ||
Entity Common Stock, Shares Outstanding (in shares) | 5,889,582 | ||
Entity Public Float | $ 10,163,739 | ||
Entity Shell Company | false | ||
Document Type | 10-K | ||
Document Period End Date | Mar. 31, 2019 | ||
Document Fiscal Year Focus | 2019 | ||
Document Fiscal Period Focus | FY | ||
Amendment Flag | false |
Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/768408/000143774919013217/cyan20190331_10k.htm
Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Cyanotech Corp.
Cyanotech Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:
Rating
Learn More![]()
Cash provided by financing activities in fiscal 2019 consists of a $1.5 million increase in borrowings against our line of credit, offset by $0.7 million in principal payments on debt and payments on short-term contract obligations and $0.1 million in proceeds from stock option exercises.
The increase in working capital was primarily the result of a $1.1 million increase in astaxanthin safety stock levels and a $0.5 million increase in accounts receivable due to the timing of sales relative to the prior year.
These costs are recorded in construction in progress and are transferred to equipment and leasehold improvements when construction is completed and the facilities are placed in service.
We will continue to focus on growing the market for our high quality, higher margin consumer products by emphasizing the higher nutritional content of our Hawaiian spirulina and the benefits of our natural astaxanthin.
As further described in the Risk Factors located in Item 1A of this Annual Report on Form 10-K, our results of operations and financial condition can be affected by numerous factors, many of which are beyond our control and could cause future results of operations to fluctuate materially as it has in the past.
Cash at March 31, 2019...Read more
Fresh water is critical for...Read more
Self-constructed leasehold improvements include design,...Read more
Additional developments during the 2019...Read more
The amount of consideration expected...Read more
Except as discussed in Note...Read more
The decline in pretax income...Read more
Changes in management's estimates could...Read more
Changes in management's estimates could...Read more
Cash used in investing activities...Read more
Revenue from extraction services is...Read more
In April 2019, we obtained...Read more
Revenue - We record revenue...Read more
We are unique in that...Read more
Future operating results may fluctuate...Read more
These activities are required to...Read more
Our production costs include customary...Read more
Equipment and leasehold improvements -...Read more
Such estimates are subject to...Read more
The asset and liability method...Read more
Customer contract liabilities consist of...Read more
The increase in working capital...Read more
Abnormal amounts of freight, handling...Read more
Financial Statements, Disclosures and Schedules
Inside this 10-K Annual Report
Material Contracts, Statements, Certifications & more
Cyanotech Corp provided additional information to their SEC Filing as exhibits
Ticker: CYAN
CIK: 768408
Form Type: 10-K Annual Report
Accession Number: 0001437749-19-013217
Submitted to the SEC: Mon Jul 01 2019 12:04:13 PM EST
Accepted by the SEC: Mon Jul 01 2019
Period: Sunday, March 31, 2019
Industry: Medicinal Chemicals And Botanical Products